United States Pollinosis Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Market size and Growth

The Global Pollinosis Market reached US$ 1.04 billion in 2023 and is expected to reach US$ 1.76 billion by 2031, growing at a CAGR of 7.0% during the forecast period 2024-2031.

Recent Mergers and acquisitions:

United States: Recent M&A Activity

✅ September 2025 - Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion. This strategic move enhances Sanofi's position in severe allergic conditions, aligning with its focus on immunology and rare diseases.

✅ June 2025 - BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6 million, aiming to advance its food allergy immunotherapy pipeline.

✅ January 2025 - Revelation Pharma, a national network of 503A and 503B compounding pharmacies, announced the acquisition of AleraCare Pharmacy. This acquisition strengthens Revelation Pharma's compounding pharmacy network, enhancing its capabilities in personalized allergy treatments.

Japan: Recent M&A Activity

✅ July 2025 - Stallergenes Greer acknowledged Shionogi's contribution and sustained commitment to improving allergy care in Japan. The company welcomed CEOLIA as a trusted new partner, aiming to advance access to allergen immunotherapy treatments and improve the quality of life for patients with respiratory allergies.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/pollinosis-market?sb

Pollinosis, commonly known as hay fever, is an allergic reaction caused by pollen exposure, leading to symptoms like sneezing, runny nose, itchy eyes, and congestion. Treatments include antihistamines, corticosteroids, and allergen immunotherapy to relieve symptoms and improve quality of life.

Key Developments:

United States: Recent Industry Developments

✅ August 2025 - Mabylon AG secured CHF 30 million in funding to advance its lead program, MY006, a tri-specific antibody targeting peanut allergens. The investment will support the completion of Phase Ia/b trials by 2027, with potential applications in treating other food allergies.

✅ May 2025 - Sanofi announced plans to invest at least $20 billion in the U.S. by 2030, focusing on expanding research and development and enhancing domestic manufacturing capabilities. This initiative aims to accelerate the availability of innovative allergy treatments and strengthen the U.S. healthcare infrastructure.

Japan: Recent Industry Developments

✅ September 2025 - ProteoBridge's technology featured in the September issue of Allergy & Rheumatic Diseases, showcasing advancements in allergen immunotherapy.

✅ July 2025 - Stallergenes Greer transitioned promotional activities for Actair® to CEOLIA Pharma in Japan, enhancing access to house dust mite allergy treatments.

✅ April 2025 - Japan Weather Association reported the highest cedar and cypress pollen concentrations in Osaka over the past decade, indicating an intense allergy season.

✅ March 2025 - Peak cedar and cypress pollen levels were observed across major cities, including Tokyo, Osaka, and Nagoya, leading to widespread allergy symptoms.

Key Players:

=> ALK-Abelló A/S, GSK plc, Sanofi, Merck & Co., Inc. Johnson & Johnson Services, Inc., Stallergenes Greer, Allergy Therapeutics, Teva Pharmaceutical Industries Ltd., HAL Allergy B.V., and LETI Pharma among others.

Growth Forecast Projected:

The Global Pollinosis Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Pollinosis Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pollinosis-market

Key Segments:

➥ By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
➥ By Allergen Source: Pollen - Tree Pollen, Grass Pollen, Weed Pollen; Mold Spores; Dust Mites
➥ By Treatment Type: Immunotherapy - Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT); Drug Class - Antihistamines, Corticosteroids, Decongestants, Leukotriene Receptor Antagonists, Others; Homeopathy, Others
➥ By End User: Hospitals & Specialty Clinics, Homecare Settings, Homeopathy, Others

Regional Analysis for Pollinosis Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Pollinosis producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Pollinosis revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pollinosis-market?sb

FAQ

What is the current size of the Pollinosis Market?

A: In 2023, the Pollinosis Market was valued at US$ 1.04 billion, reflecting its strong industry presence.

Q2: How large is the Pollinosis Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Pollinosis Market will grow to around US$ 1.76 billion , demonstrating significant expansion.

Q3: What is the growth rate of the Pollinosis Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.0% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.